Biocsl

biocsl manufactures, markets and distributes seasonal and pandemic influenza vaccine worldwide. in australia and new zealand, biocsl markets a comprehensive range of vaccines and pharmaceutical products. it also manufactures products of national significance for australia, including antivenoms and q-fever vaccine, and supplies diagnostic reagents in the australasia region. biocsl’s cold-chain logistics business ensures the integrity of csl products, as well as those of our customers, as they are safely delivered across australia. biocsl is part of the csl group which is headquartered in melbourne australia. the csl group includes csl behring, csl plasma and biocsl. with major facilities in australia, germany, switzerland and the us, csl has over 12,000 employees working in more than 27 countries.